Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Galecto Inc (GLTO)

Galecto Inc (GLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Galecto Inc 75 State Street Suite 100 Boston MA 02109 DNK

www.galecto.com Employees: 5 P: 45-7070-5210

Sector:

Medical

Description:

Galecto Inc. is a clinical stage biotechnology company with advanced programs in fibrosis and cancer centered on galectin-3 and LOXL2. The Company's pipeline includes an inhaled galectin-3 modulator currently in Phase 2b for the potential treatment of idiopathic pulmonary fibrosis. Galecto Inc. is headquarters in Copenhagen, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 34,374
Enterprise Value, $K 21,554
Shares Outstanding, K 1,597
Float, K 1,430
% Float 89.54%
Short Interest, K 169
Short Float 10.58%
Days to Cover 6.28
Short Volume Ratio 0.74
% of Insider Shareholders 10.46%
% of Institutional Shareholders 14.20%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -21,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,130 K
EBIT, $ -16,280 K
EBITDA, $ -16,190 K

Growth:

1-Year Return 339.08%
3-Year Return -67.74%
5-Year Return -92.93%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.36 on 11/06/25
Next Earnings Date 03/18/26
Earnings Per Share ttm -12.10
EPS Growth vs. Prev Qtr 9.23%
EPS Growth vs. Prev Year 30.38%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/30/24

GLTO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -147.05%
Return-on-Assets % -111.33%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.77
Book Value/Share 6.07
Interest Coverage -0.87
60-Month Beta 1.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar